Photo illustration of a card identifying the recipient of Medi-Cal services. (Image: California Healthline)When Denise Williams’ baby boy was 2 months old, she became alarmed by a rattling sound in his lungs and took him to the emergency room. While undergoing treatment, he spiraled into a disabling neurological disorder.
Solar energy units atop houses in Vista, in northern San Diego County. (Photo: Simone Hgan, via Shutterstock)OPINION: Over the past few weeks, we have seen an increase in activity and misinformation from opponents of AB 1139, California Solar Equity and Ratepayer Relief legislation, authored by Assemblymember Lorena Gonzalez (D-San Diego).
A stem cell researcher at UC Davis. (Photo: AJ Cheline, UC Davis, via The Stem Cellar)Backed by $17 million in cash from California’s stem cell agency, researchers at UC Davis this month are launching “the world’s first clinical trial using stem cells to treat spina bifida before the child is born.”
Robert Klein, left, and CIRM board member Jeff Sheey, right. At center is Board Vice Chair Art Torres. (Photo: California Stem Cell Report)The two men once worked together over the last 16 years to spend $3 billion in state funds on stem cell research in California. This week, however, they were very publicly on opposite sides of a ballot initiative to spend $5.5 billion more. The initiative is Proposition 14, which would require the state to borrow the additional billions.
A cancer stem cell researcher in the laboratory. (Photo: science photo, via Shutterstock)A $5.5 billion stem cell bond measure qualified this afternoon for the November ballot, but the campaign to win voter approval is facing an array of hurdles that its supporters never envisioned last summer when they were formulating the initiative.
A signature gatherer in Ventura during the 2018 election cycle. (Photo: Michael Gordon, via Shutterrstock)Backers of a $5.5 billion stem cell research initiative in California have suspended their efforts to gather signatures to place it on the November ballot, but are expressing confidence that the proposal will qualify. The campaign said it had run afoul of statewide bans on public gatherings.
Signature gathering in Ventura County during the 2018 election cycle. (Photo: Michael Gordon, via Shutterstock)The current coronavirus emergency and the practice of social distancing are likely to put a crimp in gathering signatures to qualify a $5.5 billion stem cell initiative for the November ballot in California.
A laboratory stem cell researcher uses a laptop in conjunction with a microscope. (Photo: moreimages, via Shutterstock)A small firm in Menlo Park, Ca., is probably the only company in the nation that is named after the number of a particular human protein. It is a small number too, only 47. But it has large implications for California’s financially strapped state stem cell agency.
A liquid nitrogen bank containing stem cells.(Photo: Alena Pavlovich, via Shutterstock) The $3 billion California stem cell agency on Monday served up the bad news with only a smattering of sugar coating. No more applications for research funding are being accepted. The cash is running out, perhaps as early as the end of August.
A stem cell researcher examines a vial in the laboratory. (Image: CI Photos, via Shutterstock)In just nine days, the California stem cell agency will take a close look at its future, examining its budget for the coming fiscal year as well as the possibilities for a ballot initiative in 2020 that could stave off its financial demise. The $3 billion enterprise, known formally as the California Institute for Regenerative Medicine (CIRM), expects to run out cash for new research awards this year, perhaps as early as September.